AEON
AEON Biopharma, Inc. Class A Common Stock (AEON)
$66
About AEON Biopharma, Inc. Class A Common Stock (AEON)
AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
Details
Daily high
$0.67
Daily low
$0.63
Price at open
$0.67
52 Week High
$1.45
52 Week Low
$0.51
Market cap
17.3M
Dividend yield
0.00%
Volume
7,891
Avg. volume
33,523
P/E ratio
-.15
AEON Biopharma, Inc. Class A Common Stock News
Details
Daily high
$0.67
Daily low
$0.63
Price at open
$0.67
52 Week High
$1.45
52 Week Low
$0.51
Market cap
17.3M
Dividend yield
0.00%
Volume
7,891
Avg. volume
33,523
P/E ratio
-.15